Skip to main content
Top
Published in: Abdominal Radiology 2/2020

01-02-2020 | Hepatic Encephalopathy | Interventional Radiology

Use of fenestration to revise shunt dysfunction after transjugular intrahepatic portosystemic shunt

Authors: Zhaonan Li, De-Chao Jiao, Guangyan Si, Xinwei Han, Wenguang Zhang, Yahua Li, Xueliang Zhou, Juanfang Liu, Jianjian Chen

Published in: Abdominal Radiology | Issue 2/2020

Login to get access

Abstract

Purpose

To explore the feasibility of fenestration in the treatment of shunt dysfunction after transjugular intrahepatic portosystemic shunt (TIPS).

Methods

Between February 2012 and December 2017, 12 TIPS patients with shunt dysfunction underwent fenestration to resolve recurrent portal hypertension with gastric variceal bleeding or ascites. The demographic data, operative data, postoperative recovery data, hemodynamic data, and complications were analyzed.

Results

Twelve patients underwent TIPS revision by fenestration, with a technical success rate of 100%. After stent reconstruction, the portal vein diameters decreased gradually with time (before the procedure: at 5 days/1 month/3 months/6 months; after procedure: 1.45 ± 0.11 cm/1.38 ± 0.06 cm/1.36 ± 0.05 cm/1.34 ± 0.05 cm/1.32 ± 0.06 cm, respectively, P = 0.057). Additionally, the blood flow velocity and blood flow rapidly increased in the portal veins and shunts after TIPS revision (P < 0.001). Surprisingly, after 3 months of stent reconstruction, the portal blood flow was 4607.99 ± 1304.10 mL/min which was even lower than the shunt flow at 4651.18 ± 612.74 mL/min. The mean pressure gradient (PSG) prior to TIPS revision was 36.71 ± 3.36 mmHg which decreased to 17.42 ± 3.37 mmHg after the procedure (P < 0.001). Clinical improvement was observed in all patients after the shunt reconstruction. Three patients (25%) had mild intra-abdominal hemorrhage at 1 week after the operation. After a mean 11.0 ± 1.24 months follow-up, ascites and bleeding were well controlled, and no stenosis of the stents was found.

Conclusions

For patients with failed TIPS revision, fenestration to reconstruct the shunt provides an excellent alternative procedure, which is effective, safe, and has a certain clinical value, for continuing the treatment of portal hypertension.
Literature
1.
go back to reference Miraglia R, Maruzzelli L, Di Piazza A, et al. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience. Cardiovasc Intervent Radiol 2019;42(1):78-86.CrossRef Miraglia R, Maruzzelli L, Di Piazza A, et al. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience. Cardiovasc Intervent Radiol 2019;42(1):78-86.CrossRef
2.
go back to reference He FL, Wang L, Yue ZD, et al. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol 2014;20(33):11835-9.CrossRef He FL, Wang L, Yue ZD, et al. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients. World J Gastroenterol 2014;20(33):11835-9.CrossRef
3.
go back to reference Sze DY, Hwang GL, Kao JS, et al. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J VASC INTERV RADIOL 2008;19(11):1653-8.CrossRef Sze DY, Hwang GL, Kao JS, et al. Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment. J VASC INTERV RADIOL 2008;19(11):1653-8.CrossRef
4.
go back to reference Liu J, Zhou C, Shi Q, et al. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2019. Liu J, Zhou C, Shi Q, et al. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2019.
5.
go back to reference Mahmoud A, Tabriz DM, Toskich BB. Laser Recanalization of a Chronically Occluded Transjugular Intrahepatic Portosystemic Shunt (TIPS). CARDIOVASC INTER RAD 2017;40(9):1473-6.CrossRef Mahmoud A, Tabriz DM, Toskich BB. Laser Recanalization of a Chronically Occluded Transjugular Intrahepatic Portosystemic Shunt (TIPS). CARDIOVASC INTER RAD 2017;40(9):1473-6.CrossRef
6.
go back to reference Miraglia R, Maruzzelli L, Tuzzolino F, et al. Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents. RADIOLOGY 2017;284(1):281-8.CrossRef Miraglia R, Maruzzelli L, Tuzzolino F, et al. Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents. RADIOLOGY 2017;284(1):281-8.CrossRef
7.
go back to reference La Mura V, Abraldes JG, Berzigotti A, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. HEPATOLOGY 2010;51(6):2108-16.CrossRef La Mura V, Abraldes JG, Berzigotti A, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. HEPATOLOGY 2010;51(6):2108-16.CrossRef
8.
go back to reference Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008;10(1):30-5.CrossRef Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008;10(1):30-5.CrossRef
9.
go back to reference Boyer TD, Haskal ZJ. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. HEPATOLOGY 2010;51(1):306.CrossRef Boyer TD, Haskal ZJ. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. HEPATOLOGY 2010;51(1):306.CrossRef
10.
go back to reference Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. HEPATOLOGY 2005;41(2):386-400.CrossRef Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. HEPATOLOGY 2005;41(2):386-400.CrossRef
11.
go back to reference Ferral H, Gomez-Reyes E, Fimmel CJ. Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era. Tech Vasc Interv Radiol 2016;19(1):82-8.CrossRef Ferral H, Gomez-Reyes E, Fimmel CJ. Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era. Tech Vasc Interv Radiol 2016;19(1):82-8.CrossRef
12.
go back to reference Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents. RADIOLOGY 2006;241(1):298-305.CrossRef Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents. RADIOLOGY 2006;241(1):298-305.CrossRef
13.
go back to reference Qi XS, Bai M, Yang ZP, et al. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol 2014;20(21):6470-80.CrossRef Qi XS, Bai M, Yang ZP, et al. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol 2014;20(21):6470-80.CrossRef
14.
go back to reference Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010;25(11):1718-25.CrossRef Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010;25(11):1718-25.CrossRef
15.
go back to reference Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J HEPATOL 2014;60(5):962-8.CrossRef Perarnau JM, Le Gouge A, Nicolas C, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J HEPATOL 2014;60(5):962-8.CrossRef
16.
go back to reference Bureau C, Garcia PJ, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. LIVER INT 2007;27(6):742-7.CrossRef Bureau C, Garcia PJ, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. LIVER INT 2007;27(6):742-7.CrossRef
17.
go back to reference Fidelman N, Kwan SW, LaBerge JM, et al. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol 2012;199(4):746-55.CrossRef Fidelman N, Kwan SW, LaBerge JM, et al. The transjugular intrahepatic portosystemic shunt: an update. AJR Am J Roentgenol 2012;199(4):746-55.CrossRef
18.
go back to reference Larson M, Kirsch D, Kay D. Clinical Images: Parallel Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Setting of TIPS Occlusion. Ochsner J 2016;16(2):113-5.PubMedPubMedCentral Larson M, Kirsch D, Kay D. Clinical Images: Parallel Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Setting of TIPS Occlusion. Ochsner J 2016;16(2):113-5.PubMedPubMedCentral
19.
go back to reference Tanaka T, Gunther RW, Isfort P, et al. Pull-through technique for recanalization of occluded portosystemic shunts (TIPS): technical note and review of the literature. Cardiovasc Intervent Radiol 2011;34(2):406-12.CrossRef Tanaka T, Gunther RW, Isfort P, et al. Pull-through technique for recanalization of occluded portosystemic shunts (TIPS): technical note and review of the literature. Cardiovasc Intervent Radiol 2011;34(2):406-12.CrossRef
20.
go back to reference Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci 2016;6:29.CrossRef Owen JM, Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography. J Clin Imaging Sci 2016;6:29.CrossRef
21.
go back to reference Parvinian A, Gaba RC. Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage. Semin Intervent Radiol 2014;31(3):252-7.CrossRef Parvinian A, Gaba RC. Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage. Semin Intervent Radiol 2014;31(3):252-7.CrossRef
22.
go back to reference Luo S, Chu J, Huang H, et al. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. WORLD J GASTROENTERO 2017;23(26):4779.CrossRef Luo S, Chu J, Huang H, et al. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. WORLD J GASTROENTERO 2017;23(26):4779.CrossRef
23.
go back to reference Cura M, Cura A, Suri R, et al. Causes of TIPS dysfunction. AJR Am J Roentgenol 2008;191(6):1751-7.CrossRef Cura M, Cura A, Suri R, et al. Causes of TIPS dysfunction. AJR Am J Roentgenol 2008;191(6):1751-7.CrossRef
24.
go back to reference Clark TW, Agarwal R, Haskal ZJ, et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts. J VASC INTERV RADIOL 2004;15(2 Pt 1):147-52.CrossRef Clark TW, Agarwal R, Haskal ZJ, et al. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts. J VASC INTERV RADIOL 2004;15(2 Pt 1):147-52.CrossRef
25.
go back to reference Harrod-Kim P, Saad WE, Waldman D. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J VASC INTERV RADIOL 2006;17(10):1605-10.CrossRef Harrod-Kim P, Saad WE, Waldman D. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J VASC INTERV RADIOL 2006;17(10):1605-10.CrossRef
26.
go back to reference Sauerbruch T, Mengel M, Dollinger M, et al. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. GASTROENTEROLOGY 2015;149(3):660-8.CrossRef Sauerbruch T, Mengel M, Dollinger M, et al. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy. GASTROENTEROLOGY 2015;149(3):660-8.CrossRef
27.
go back to reference Wang Q, Lv Y, Bai M, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J HEPATOL 2017;67(3):508-16.CrossRef Wang Q, Lv Y, Bai M, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J HEPATOL 2017;67(3):508-16.CrossRef
Metadata
Title
Use of fenestration to revise shunt dysfunction after transjugular intrahepatic portosystemic shunt
Authors
Zhaonan Li
De-Chao Jiao
Guangyan Si
Xinwei Han
Wenguang Zhang
Yahua Li
Xueliang Zhou
Juanfang Liu
Jianjian Chen
Publication date
01-02-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02329-0

Other articles of this Issue 2/2020

Abdominal Radiology 2/2020 Go to the issue